Immunological Response After Shrimp Oral Immunotherapy Treatment

Status Recruiting

Clinical Trial Summary

Oral immunotherapy is effective in desensitized food allergy. Shrimp allergy is increasing in Thailand. So the purpose of our study is to determine level of specific immunoglobulin E antibodies to shrimp, Immunoglobulin G4 and immunoblot analysis in shrimp allergy patients after shrimp oral immunotherapy.

Clinical Trial Description

All subject in this study were sensitized to shrimp. All patient was clinically evaluated, with focus on shrimp allergy by medical history, medical examination and gold standard oral food challenge test. Compare oral immunotherapy to shrimp and shrimp avoidance. Blood sample was taken for baseline determination of immunoglobulin E antibodies to shrimp. The primary outcome was the specific immunoglobulin E antibodies to shrimp,Immunoglobulin G4 and immunoblot analysis in case that oral immunotherapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04552522
Study type	Interventional
Source	Mahidol University
Contact	Punchama Pacharn, MD
Phone	024197000
Email	punchama@gmail.com
Status	Recruiting
Phase	N/A
Start date	August 28, 2020
Completion date	July 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05161572` - Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer	Phase 2
Recruiting	`NCT05176002` - Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.	Phase 1/Phase 2
Not yet recruiting	`NCT05848011` - A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer	Phase 2
Recruiting	`NCT04500990` - MRI DWI None-Gaussian Model Predicting Early Response to Immunotherapy in Digestive System Malignancies: a Prospective Observational Study
Not yet recruiting	`NCT04372732` - Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLC
Completed	`NCT02692976` - Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients	Phase 2
Completed	`NCT03763630` - MAPS & ITEC Cohorts: 6-8 Years Follow-up	Phase 2
Recruiting	`NCT05515796` - Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors	Phase 2
Recruiting	`NCT04711330` - Response and Toxicity Prediction by Microbiome Analysis After Concurrent Chemoradiotherapy
Not yet recruiting	`NCT05479240` - Short-range Radiotherapy Sequential Tislelizumab Combined With Chemotherapy Versus Long Range Radiotherapy and Chemotherapy Combined With Tislelizumab Neoadjuvant Therapy for Locally Advanced Rectal Cancer	Phase 2
Recruiting	`NCT03683407` - Effect of Chemotherapy on TMB in NSCLC
Recruiting	`NCT03701607` - Effect of Chemotherapy on PD-L1 in NSCLC
Completed	`NCT03357861` - Cancer Patients Treated With Immunotherapy in Intensive Care Unit
Recruiting	`NCT05223088` - Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer	Phase 2
Recruiting	`NCT05657262` - Effect of Z Technıque on Pain, Comfort, Symptoms in Ummunotherapy Areas	N/A
Recruiting	`NCT05621356` - Monitoring Allergen Immunotherapy in Allergic Rhinitis
Active, not recruiting	`NCT03066986` - Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)	Phase 1/Phase 2
Recruiting	`NCT05025514` - Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer.
Active, not recruiting	`NCT05740800` - Patient Care Needs and the Decision-Making Experience of Patients With Cancer and Family Caregivers Regarding Immunotherapy: A Qualitative and Quantitative Mixed Methods Study
Not yet recruiting	`NCT04587817` - Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors